| NCT ID | NCT06895824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University College London Hospitals |
| Condition | Tinnitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-12-11 |
| Primary Completion | 2025-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-12-11 with a primary completion date of 2025-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
We are examining the effect of mindfulness meditation on attitudes towards tinnitus, as well as physical and psychological distress associated with the condition. The meditation is designed to promote neuroplasticity, fostering new neural connections to help you reinterpret tinnitus through a lens of safety and reduce the perception of threat. This approach integrates several techniques from various psychological therapies which have been promising in reducing tinnitusrelated distress. Therefore, the purpose of this study is to see whether a guided mindfulness meditation intervention is effective in improving the acceptance of tinnitus symptoms, as well as reducing tinnitus-related distress in people living with tinnitus.
Eligibility Criteria
Inclusion Criteria: * Experiencing distressing tinnitus * Sufficient English language and hearing ability to take part * Completed all relevant medical and audiological investigations and concluded ensuing treatment for any underlying disease * Not be engaging in any other therapy for tinnitus. Exclusion Criteria: * Risk to self (scoring 'nearly every day' on PHQ-9 question "Thoughts that you would be better off dead, or of hurting yourself in some way?") * Severe mental health difficulties (PHQ-9 score of 20 or more)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06895824 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06895824 currently recruiting?
Yes, NCT06895824 is actively recruiting participants. Contact the research team at florian.vogt@nhs.net for enrollment information.
Where is the NCT06895824 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT06895824 clinical trial?
NCT06895824 is sponsored by University College London Hospitals. The trial plans to enroll 100 participants.